Advertisement

Parasitology Research

, Volume 118, Issue 9, pp 2455–2466 | Cite as

Therapeutic efficacy of nanocompounds in the treatment of cystic and alveolar echinococcoses: challenges and future prospects

  • Nayer Mehdizad Bakhtiar
  • Abolfazl Akbarzadeh
  • Adriano Casulli
  • Mahmoud Mahami-Oskouei
  • Ehsan Ahmadpour
  • Sanam Nami
  • Ali Rostami
  • Adel SpotinEmail author
Treatment and Prophylaxis - Review
  • 108 Downloads

Abstract

Echinococcus granulosus sensu lato and E. multilocularis are the causative agents of life-threatening cystic and alveolar echinococcoses (CE and AE), respectively, which lead to serious public health concerns across the globe. Benzimidazoles (BMZs) are the drugs of choice for the treatment of human CE and AE. Presently, the chemotherapeutic failures of BMZs against CE and AE are caused by their low aqueous solubility, poor absorption, and consequently their erratic bioavailability. Among the BMZ compounds used for CE/AE treatment, albendazole (ABZ) and mebendazole (MBZ) are the only drugs licensed for human use. Nevertheless, the administration of these BMZs for a long period of time leads to undesirable adverse effects. Therefore, there is an urgent need for designing new formulations of BMZs with increased bioavailability. To bridge these therapeutic gaps, nanoparticle enantiomers of ABZ and drug delivery systems based on nanostructured entities currently provide an interesting new formulation of already existing drugs to improve the pharmacokinetic effects of BMZs. This study provides an overview of the tested nanocompounds against E. granulosus and E. multilocularis, including their effective dose, type of nanoparticles (NPs), assay setting, and therapeutic outcomes. This review suggests that BMZ derivatives loaded in NPs can significantly improve the scolicidal and cysticidal activities compared with single BMZ. Moreover, BMZ-loaded polymeric NPs show a tendency to increase mortality rate against protoscoleces and microcysts compared with metallic formulations, nanoemulsions, lipid nanocapsules, solid lipid NPs, liposomes, and nanocrystals. In the future, the use of the newly structured entities, attained by bridging ligands to the modified surface of NPs, as well as the electromagnetically produced nanodrugs could be helpful for developing fine-tuned formulations as an alternative to the already existing drugs against these neglected parasitic infections.

Keywords

Nanocompounds Scolicidal agents Cystic echinococcosis Alveolar echinococcosis Benzimidazoles 

Abbreviations

BMZs

Benzimidazoles

ABZ

Albendazole

MBZ

Mebendazole

NPs

Nanoparticles

NEs

Nanoemulsions

NCs

Nanocrystals

MNPs

Metallic NPs

PZQ

Praziquantel

SeNPs

Selenium NPs

AgNPs

Silver NPs

ZnONPs

Zinc oxide NPs

SLNs

Solid lipid NPs

ABZSO

Albendazole sulfoxide

L-ABZ

Liposomized albendazole

mPEG-PCL

Methoxy polyethylene glycol-polycaprolactone

PLGA-PEG

Polylactic-co-glycolic acid

PLA

Polylactide

ChABZ

Chitosan-albendazole

ChPZQ

Chitosan-praziquantel

Notes

Funding information

This is a report of a database from the thesis entitled “Therapeutic efficacy of nanocompounds in the treatment of cystic and alveolar echinococcoses: An updated review and future prospects” registered at the Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran (Grant Thesis No. 59631). This work was also partially supported by ERANet-LAC 2nd Joint Call (http://www.eranet-lac.eu) and the Italian Ministry of Health - NDTND project.

Compliance with ethical standards

Conflict of interest

The authors declare that there is no conflict of interest.

References

  1. Abulaihaiti M, Wu XW, Qiao L, Lv HL, Zhang HW, Aduwayi N, Wang YJ, Wang XC, Peng XY (2015) Efficacy of albendazole-chitosan microsphere-based treatment for alveolar echinococcosis in mice. PLoS Negl Trop Dis 9(9):e0003950PubMedPubMedCentralGoogle Scholar
  2. Ahmadnia S, Moazeni M, Mohammadi-Samani S, Oryan A (2013) In vivo evaluation of the efficacy of albendazole sulfoxide and albendazole sulfoxide loaded solid lipid nanoparticles against hydatid cyst. Exp Parasitol 135(2):314–319PubMedGoogle Scholar
  3. Akbarzadeh A, Rezaei-Sadabady R, Davaran S, Joo SW, Zarghami N, Hanifehpour Y, Samiei M, Kouhi M, Nejati-Koshki K (2013) Liposome: classification, preparation, and applications. Nanoscale Res Lett 8(1):102PubMedPubMedCentralGoogle Scholar
  4. Aminpour S, Rafiei A, Jelowdar A, Kouchak M (2019) Evaluation of the protoscolicidal effects of albendazole and albendazole loaded solid lipid nanoparticles. Iran J Parasitol 14(1):127–135PubMedPubMedCentralGoogle Scholar
  5. Barabadi H, Honary S, Mohammadi MA, Ahmadpour E, Rahimi MT, Alizadeh A, Naghibi F, Saravanan M (2017) Green chemical synthesis of gold nanoparticles by using Penicillium aculeatum and their scolicidal activity against hydatid cyst protoscolices of Echinococcus granulosus. Environ Sci Pollut Res Int 24(6):5800–5810PubMedGoogle Scholar
  6. Bhatia S (2016) Nanoparticles types, classification, characterization, fabrication methods and drug delivery applications natural polymer drug delivery systems. Springer, p 33–93Google Scholar
  7. Brunetti E, Kern P, Vuitton DA (2010) Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Tropica 114(1):1–16Google Scholar
  8. Cong TT, Faivre V, Nguyen TT, Heras H, Pirot F, Walchshofer N, Sarciron ME, Falson F (2008) Study on the hydatid cyst membrane: permeation of model molecules and interactions with drug-loaded nanoparticles. Int J Pharm 353(1–2):223–232Google Scholar
  9. De S, Pan D, Bera AK, Sreevatsava V, Bandyopadhyay S, Chaudhuri D, Kumar S, Rana T, Das S, Das SK, Suryanaryana VV (2012) In vitro assessment of praziquantel and a novel nanomaterial against protoscoleces of Echinococcus granulosus. J Helminthol 86(1):26–29PubMedGoogle Scholar
  10. Dvorožňáková E, Hrčková G, Borošková Z, Velebný S, Dubinský P (2004) Effect of treatment with free and liposomized albendazole on selected immunological parameters and cyst growth in mice infected with Echinococcus multilocularis. Parasitol Int 53(4):315–325PubMedGoogle Scholar
  11. Eckert J, Deplazes P (2004) Biological, epidemiological, and clinical aspects of echinococcosis, a zoonosis of increasing concern. Clin Microbiol Rev 17(1):107–135PubMedPubMedCentralGoogle Scholar
  12. Fakhar M, Chabra A, Rahimi-Esboei B, Rezaei F (2015) In vitro protoscolicidal effects of fungal chitosan isolated from Penicillium waksmanii and Penicillium citrinum. J Parasit Dis 39(2):162–167PubMedGoogle Scholar
  13. Farhadi M, Haniloo A, Rostamizadeh K, Faghihzadeh S (2018) Efficiency of flubendazole-loaded mPEG-PCL nanoparticles: a promising formulation against the protoscoleces and cysts of Echinococcus granulosus. Acta Trop 187:190–200PubMedGoogle Scholar
  14. Forrest ML, Kwon GS (2008) Clinical developments in drug delivery nanotechnology. Adv Drug Deliv Rev 60(8):861PubMedGoogle Scholar
  15. Ghabouli-Mehrabani N, Kousha A, Khalili M, Mahami-Oskouei M, Mohammadzadeh M, Alizadeh S, Maleksabet A, Hamidi F (2014) Hydatid cyst surgeries in patients referred to hospitals in East Azerbaijan province during 2009-2011. Iran J Parasitol 9:233e238Google Scholar
  16. Gutiérrez V, Seabra AB, Reguera RM, Khandare J, Calderón M (2016) New approaches from nanomedicine for treating leishmaniasis. Chem Soc Rev 45(1):152–168PubMedGoogle Scholar
  17. Hajizadeh M, Ahmadpour E, Sadat AT, Spotin A (2013) Hydatidosis as a cause of acute appendicitis: a case report. Asian Pac J Trop Dis 3(1):71–73PubMedCentralGoogle Scholar
  18. Hasan S (2015) A review on nanoparticles: their synthesis and types. Res J Recent Sci, ISSN 2277:2502Google Scholar
  19. Hemphill A, Stadelmann B, Rufener R, Spiliotis M, Boubaker G, Müller J, Müller N, Gorgas D, Gottstein B (2014) Treatment of echinococcosis: albendazole and mebendazole–what else? Parasite 21:70PubMedPubMedCentralGoogle Scholar
  20. Heurtault B, Saulnier P, Pech B, Proust J-E, Benoit J-P (2002) A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm Res 19(6):875–880PubMedGoogle Scholar
  21. Higuita NI, Brunetti E, McCloskey C (2016) Cystic echinococcosis. J Clin Microbiol 54(3):518–523Google Scholar
  22. Huynh NT, Passirani C, Saulnier P, Benoit J-P (2009) Lipid nanocapsules: a new platform for nanomedicine. Int J Pharm 379(2):201–209PubMedGoogle Scholar
  23. Jaiswal M, Dudhe R, Sharma P (2015) Nanoemulsion: an advanced mode of drug delivery system. 3. Biotech 5(2):123–127Google Scholar
  24. Razi JM, Alborzi A, Najafzade Varzi H, Ghorbanpour M, Derakhshan L (2015) Survey on effects of albendazole, Echinacea purpurea, sambucus ebulus and zinc oxide nanoparticles on unilocular hydatid cyst in mice. Iran J Vet Res 11(2):68–76.  https://doi.org/10.22055/ivj.2015.10114 Google Scholar
  25. Jelowdar A, Rafiei A, Abbaspour MR, Rashidi I, Rahdar M (2017) Efficacy of combined albendazol and praziquntel and their loaded solid lipid nanoparticles components in chemoprophylaxis of experimental hydatidosis. Asian Pac J Trop Biomed 7(6):549–554Google Scholar
  26. Joshi MD, Müller RH (2009) Lipid nanoparticles for parenteral delivery of actives. Eur J Pharm Biopharm 71(2):161–172PubMedGoogle Scholar
  27. Junghanns J-UA, Müller RH (2008) Nanocrystal technology, drug delivery and clinical applications. Int J Nanomedicine 3(3):295PubMedPubMedCentralGoogle Scholar
  28. Kohansal MH, Nourian A, Rahimi MT, Daryani A, Spotin A, Ahmadpour E (2017) Natural products applied against hydatid cyst protoscolices: a review of past to present. Acta Trop 176:385–394PubMedGoogle Scholar
  29. Lacoeuille F, Hindré F, Moal F, Roux J, Passirani C, Couturier O, Calès P, Le Jeune JJ, Lamprecht A, Benoit JP (2007) In vivo evaluation of lipid nanocapsules as a promising colloidal carrier for paclitaxel. Int J Pharm 344(1–2):143–149PubMedGoogle Scholar
  30. Lashkarizadeh MR, Asgaripour K, Dezaki ES, Harandi MF (2015) Comparison of scolicidal effects of amphotricin B, silver nanoparticles, _and Foeniculum vulgare Mill on hydatid cysts protoscoleces. Iran J Parasitol 10(2):206PubMedPubMedCentralGoogle Scholar
  31. Li H, Song T, Shao Y, Tuergan A, Ran B, Wen H (2013) Chemotherapy in alveolar echinococcosis of multi-organs: what’s the role? Parasitol Res 112(6):2237–2243PubMedGoogle Scholar
  32. Liance M, Nemati F, Bories C, Couvreur P (1993) Experience with doxorubicin-bound polyisohexylcyanoacrylate nanoparticles on murine alveolar echinococcosis of the liver. Int J Parasitol 23(3):427–429PubMedGoogle Scholar
  33. Lötsch F, Naderer J, Skuhala T, Groger M, Auer H, Kaczirek K, Waneck F, Ramharter M (2016) Intra-cystic concentrations of albendazole-sulphoxide in human cystic echinococcosis: a systematic review and analysis of individual patient data. Parasitol Res 115(8):2995–3001PubMedPubMedCentralGoogle Scholar
  34. Lv H, Jiang Y, Liao M, Sun H, Zhang S, Peng X (2013) In vitro and in vivo treatments of Echinococcus granulosus with Huaier aqueous extract and albendazole liposome. Parasitol Res 112(1):193–198PubMedGoogle Scholar
  35. Mahami Oskouei M, Mehrabani NG, Miahipour E (2016) Molecular characterization and sequence analysis of Echinococcus granulosus from sheep isolates in East Azerbaijan province, northwest of Iran. J Parasit Dis 40:785–790PubMedGoogle Scholar
  36. Mahmoudvand H, Harandi MF, Shakibaie M, Aflatoonian MR, ZiaAli N, Makki MS, Jahanbakhsh S (2014) Scolicidal effects of biogenic selenium nanoparticles against protoscolices of hydatid cysts. Int J Surg 12(5):399–403PubMedGoogle Scholar
  37. Malekifard F (2017) Solicidal effect of the gold nanoparticle on protoscoleces of hydratid cyst in vitro. J Urmia Univ Med Sci 28(2):130–137Google Scholar
  38. Moazeni M, Borji H, Darbandi MS, Saharkhiz MJ (2017) In vitro and in vivo antihydatid activity of a nano emulsion of Zataria multiflora essential oil. Res Vet Sci 114:308–312PubMedGoogle Scholar
  39. Mody VV, Siwale R, Singh A, Mody HR (2010) Introduction to metallic nanoparticles. J Pharm Bioallied Sci 2(4):282–289PubMedPubMedCentralGoogle Scholar
  40. Napooni S, Arbabi M, Delavari M, Hooshyar H, Rasti S (2018) Lethal effects of gold nanoparticles on protoscolices of hydatid cyst: in vitro study. Comp Clin Pathol 28:143–150 1–8Google Scholar
  41. Naseri M, Akbarzadeh A, Spotin A, Akbari NAR, Mahami-Oskouei M, Ahmadpour E (2016) Scolicidal and apoptotic activities of albendazole sulfoxide and albendazole sulfoxide-loaded PLGA-PEG as a novel nanopolymeric particle against Echinococcus granulosus protoscoleces. Parasitol Res 115(12):4595–4603PubMedGoogle Scholar
  42. Paredes A, de Campos Lourenço T, Marzal M, Rivera A, Dorny P, Mahanty S, Guerra-Giraldez C, García HH, Nash TE, Cass QB, Cysticercosis Working Group in Peru (2013) In vitro analysis of albendazole sulfoxide enantiomers shows that (+)-(R)-albendazole sulfoxide is the active enantiomer against Taenia solium. Antimicrob Agents Chemother 57(2):944–949PubMedPubMedCentralGoogle Scholar
  43. Pensel P, Paredes A, Albani CM, Allemandi D, Bruni SS, Palma SD, Elissondo MC (2018) Albendazole nanocrystals in experimental alveolar echinococcosis: enhanced chemoprophylactic and clinical efficacy in infected mice. Vet Parasitol 251:78–84PubMedGoogle Scholar
  44. Pensel PE, Gamboa GU, Fabbri J, Ceballos L, Bruni SS, Alvarez LI, Allemandi D, Benoit JP, Palma SD, Elissondo MC (2015) Cystic echinococcosis therapy: albendazole-loaded lipid nanocapsules enhance the oral bioavailability and efficacy in experimentally infected mice. Acta Trop 152:185–194PubMedGoogle Scholar
  45. Prabhu RH, Patravale VB, Joshi MD (2015) Polymeric nanoparticles for targeted treatment in oncology: current insights. Int J Nanomedicine 10:1001PubMedPubMedCentralGoogle Scholar
  46. Rahimi-Esboei B, Fakhar M, Chabra A, Hosseini M (2013) In vitro treatments of Echinococcus granulosus with fungal chitosan, as a novel biomolecule. Asian Pac J Trop Biomed 3(10):811–815PubMedPubMedCentralGoogle Scholar
  47. Rahimi MT, Ahmadpour E, Esboei BR, Spotin A, Koshki MH, Alizadeh A, Honary S, Barabadi H, Mohammadi MA (2015) Scolicidal activity of biosynthesized silver nanoparticles against Echinococcus granulosus protoscolices. Int J Surg 19:128–133PubMedGoogle Scholar
  48. Rodrigues J Jr, Bories C, Emery I, Fessi H, Devissaguet J, Liance M (1995) Development of an injectable formulation of albendazole and in vivo evaluation of its efficacy against Echinococcus multilocularis metacestode. Int J Parasitol 25(12):1437–1441PubMedGoogle Scholar
  49. Rostami A, Mozafari M, Gholipourmalekabadi M, Caicedo HH, Lasjerdi Z, Sameni M, Samadikuchaksaraei A (2015) Optimization of fluoride-containing bioactive glasses as a novel scolicidal agent adjunct to hydatid surgery. Acta Trop 148:105–114PubMedGoogle Scholar
  50. Schipper NG, Olsson S, Hoogstraate JA, de Boer AG, Vårum KM, Artursson P (1997) Chitosans as absorption enhancers for poorly absorbable drugs 2: mechanism of absorption enhancement [J]. Pharm Res 14(7):923–929PubMedGoogle Scholar
  51. Sharma N, Bansal M, Visht S, Sharma P, Kulkarni G (2010) Nanoemulsion: a new concept of delivery system. Chron Young Sci 1(2):2Google Scholar
  52. Shuhua X, Jiqing Y, Mingjie W, Pieying J, Fanghua G, Junjie C, Wei J, Hotez P (2002) Augmented bioavailability and cysticidal activity of albendazole reformulated in soybean emulsion in mice infected with Echinococcus granulosus or Echinococcus multilocularis. Acta Trop 82(1):77–84PubMedGoogle Scholar
  53. Siles-Lucas M, Casulli A, Cirilli R, Carmena D (2018) Progress in the pharmacological treatment of human cystic and alveolar echinococcosis: compounds and therapeutic targets. PLoS Negl Trop Dis 12(4):e0006422PubMedPubMedCentralGoogle Scholar
  54. Siles-Lucas M, Hemphill A (2002) Cestode parasites: application of in vivo and in vitro models for studies on the host-parasite relationship. Adv Parasitol 51:134–230Google Scholar
  55. Silva M, Mirza D, Bramhall S, Mayer A, McMaster P, Buckels J (2004) Treatment of hydatid disease of the liver. Dig Surg 21(3):227–234PubMedGoogle Scholar
  56. Singla R, Guliani A, Kumari A, Yadav SK (2016) Metallic nanoparticles, toxicity issues and applications in medicine nanoscale materials in targeted drug delivery, theragnosis and tissue regeneration. Springer, p 41–80Google Scholar
  57. Smego RA Jr, Sebanego P (2005) Treatment options for hepatic cystic echinococcosis. IInt J Infect Dis 9(2):69–76Google Scholar
  58. Soltani S, Rafiei A, Ramezani Z, Abbaspour MR, Jelowdar A, Kahvaz MS (2017) Evaluation of the hydatid cyst membrane permeability of albendazole and albendazole sulfoxide-loaded solid lipid nanoparticles. Jundishapur J Nat Pharm Prod 12(2)Google Scholar
  59. Stojkovic M, Zwahlen M, Teggi A, Vutova K, Cretu CM, Virdone R, Nicolaidou P, Cobanoglu N, Junghanss T (2009) Treatment response of cystic echinococcosis to benzimidazoles: a systematic review. PLoS Negl Trop Dis 3(9):e524PubMedPubMedCentralGoogle Scholar
  60. Torabi N, Dobakhti F, Faghihzadeh S, Haniloo A (2018) In vitro and in vivo effects of chitosan-praziquantel and chitosan-albendazole nanoparticles on Echinococcus granulosus Metacestodes. Parasitol Res 117:1–9Google Scholar
  61. Wen H, New RR, Muhmut M, Wang JH, Wang YH, Zhang JH, Shao YM, Craig PS (1996) Pharmacology and efficacy of liposome-entrapped albendazole in experimental secondary alveolar echinococcosis and effect of co-administration with cimetidine. Parasitology 113(2):111–121PubMedGoogle Scholar
  62. Wilczewska AZ, Niemirowicz K, Markiewicz KH, Car H (2012) Nanoparticles as drug delivery systems. Pharmacol Rep 64(5):1020–1037PubMedGoogle Scholar
  63. Wissing S, Kayser O, Müller R (2004) Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev 56(9):1257–1272Google Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  • Nayer Mehdizad Bakhtiar
    • 1
    • 2
  • Abolfazl Akbarzadeh
    • 3
  • Adriano Casulli
    • 4
    • 5
  • Mahmoud Mahami-Oskouei
    • 2
  • Ehsan Ahmadpour
    • 2
  • Sanam Nami
    • 2
  • Ali Rostami
    • 6
  • Adel Spotin
    • 1
    • 7
    Email author
  1. 1.Immunology Research CenterTabriz University of Medical SciencesTabrizIran
  2. 2.Department of Parasitology and Mycology, Faculty of MedicineTabriz University of Medical SciencesTabrizIran
  3. 3.Drug Applied Research CenterTabriz University of Medical SciencesTabrizIran
  4. 4.WHO Collaborating Centre for the Epidemiology, Detection and Control of Cystic and Alveolar Echinococcosis, Department of Infectious DiseasesIstituto Superiore di SanitàRomeItaly
  5. 5.European Union Reference Laboratory for Parasites (EURLP), Department of Infectious DiseasesIstituto Superiore di SanitàRomeItaly
  6. 6.Infectious Diseases and Tropical Medicine Research Center, Health Research InstituteBabol University of Medical SciencesBabolIran
  7. 7.Student Research CommitteeTabriz University of Medical SciencesTabrizIran

Personalised recommendations